Polyunsaturated fatty acids, such as arachidonic acid, are accumulated in brain and induce neuronal differentiation. Arachidonic acid is metabolized to epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids (HETEs) by cytochrome P450s. In this study, we found that 14,15-EET and 20-HETE-enhanced NGF-induced rat pheochromocytoma PC12 cell neurite outgrowth even at the concentration of 100 nmol L −1 . LC-MS analysis revealed that 14,15-EET was effectively produced from arachidonic acid by rat CYP2C11, 2C13, and 2C23, and these P450s were 14,15-EET also enhanced neurite outgrowth of primary cultured neuron from rat hippocampus. This study suggests that arachidonic acid metabolites produced by P450 contribute to neurite outgrowth through calcium influx.
(HETEs). 5 Furthermore, EETs are metabolized to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH).
There are many HETE isomers produced by P450s, including 5, 8, 9, 11, 12, 15, 16, 17, 18, 19 , and 20-HETEs. 6 19-HETE is a stimulator of renal Na + -K + -ATPase 7 and 20-HETE is a potent vasoconstrictor in isolated rat aortas. 8 EETs were initially identified as endotheliumderived hyperpolarizing factors (EDHFs) 9 and attracted much interest. However, EETs are now suggested to be more than just vasodilators. EETs were also found to influence many biological processes, including ion channel regulation, mitogenesis, and inflammation. 10 There are four EET isomers, 5,6-, 8,9-, 11,12-, and 14,15-EET.
11,12-EET and 14,15-EET were demonstrated to be powerful mitogens, using kidney-and endothelium-derived culture cells. 11 11,12- EET is also involved in angiogenesis under hypoxic conditions. 12 Although specific receptors for EETs and HETEs have not been identified, EETs activate some receptors such as Ca 2+ -activated K + channels and transient receptor potential (TRP) channels. 13 In the brain, HETEs and EETs are released from neurons, astrocytes, and cerebral blood vessels, and contribute to cerebral blood flow and angiogenesis, 14 but their effects on neural functions are not well understood. The neurite outgrowth of neurons is very important for the function of the central nervous system. Rat phenochromocytoma PC12 cells are used as a model system for neurodegenerative diseases and as an in vitro model system to study cell differentiation. Nerve growth factor (NGF) induces neural differentiation of PC12 cells, leading to neurite outgrowth. NGF also induces expression of phospholipase A 2 in PC12 cells. 15 We also used primary cultured neuron isolated from rat fetal hippocampus. In this study, we investigate biological functions of metabolites of arachidonic acid by P450s in neurite outgrowth of these cells. 2C23, 2E1, 4A2, sEH, NADPH-cytochrome P450 reductase, and β-actin were prepared as described previously. [16] [17] [18] β-NADPH was purchased from Oriental Yeast Co. LTD (Tokyo, Japan), horse serum was from Equitech-Bio (Kerrville, TX), and nerve growth factor (NGF) was form Alomone Labs (Jerusalem, Israel). HC067047 and Fura-2 AM were from Abcam plc (Cambridge, UK). Fluo-4AM was from AAT Bioquest (Sunnyvale, CA).
| MATERIALS AND METHODS

| Materials
Dulbecco
| Cell culture and PC12 cell neurite extension
Rat pheochromocytoma (PC12) cells were obtained from RIKEN cell bank (Tsukuba, Japan). Cells were cultured in DMEM containing 10% horse serum, 5% fetal calf serum(FCS), penicillin (100 units/mL), and streptomycin (100 μg/mL), and maintained at 37°C in 5% CO 2 and 95% air. For the neurite outgrowth assay, cells were seeded at Neurite length of differentiated cells was measured using Image J.
| Isolation of rat hippocampal neuronal calls
Neuron-rich cultures were prepared from hippocampus of Wistar rats (Clea Japan, Inc., Tokyo) at embryonic day 18 as described previously. 19, 20 Immuno-enhancer solution (Wako, Osaka, Japan). Image was obtained by confocal microscopy (Nikon A1, Nikon, Tokyo, Japan). All experiments were conducted in accordance with guidelines on the welfare of experimental animals and with the approval of the Ethics Committee on the use of animals of Kwansei Gakuin University.
| Arachidonic acid metabolism by P450s
Purification of rat P450 (CYP1A1, 1A2, 2A1, 2B1, 2C11, 2C13, 2C23, 2D1, 2E1, 2J3, 4A2, and 4F1), NADPH-cytochrome P450 reductase, and cytochrome b 5 was performed as described previously. 23, 24 The reaction of arachidonic acid with P450 was carried out by the method described previously with a brief modification. 6, 23, 25 
| Statistical analysis
The differential significance of the results obtained was determined by One-way ANOVA followed by a Bonferroni/Dunn post hoc test, and P < 0.05 was considered statistically significant.
| RESULTS
| Effects of EETs and HETEs on NGF-induced neurite outgrowth of PC12 cell
As unsaturated fatty acids, such as arachidonic acid, are reported to enhance PC12 cell neurite outgrowth, effects of arachidonic acid EET was most efficiently produced by CYP2C23. Dihydroxyeicosatrienoic acids (DHETs) were not produced in these conditions.
| Presence of P450s producing 14,15-EET in PC12 cells
We found that the most effective arachidonic acid metabolites to enhance neurite outgrowth of PC12 cells were 14,15-EET which mainly produced by CYP2C and 2E1, and 20-HETE produced by CYP4A (Figures 1 and 2 ). Next, we investigated protein levels of P450s which produce 14,15-EET or 20-HETE in PC12 cells ( Figure 3A) . CYP2C11, 2C13, and 2C23 were clearly detected in PC12 cells. However, CYP4A2, which produces 20-HETE, was not detected. NADPH-cytochrome P450 reductase and sEH proteins were detected in PC12 cells.
| Inhibition of PC12 cell neurite outgrowth by P450 inhibitors
To investigate the contribution of 14,15-EET-producing P450 to PC12
cell neurite outgrowth, cells were treated with P450 inhibitors. First, we OGURO ET AL. 28 On the other hand, the sEH inhibitor, DCU, enhanced NGF-induced neurite outgrowth ( Figures 3D and E) .
| Inhibition of calcium influx and neurite outgrowth in PC12 cells by TRP inhibitors
Although the receptors for EETs remain unknown, EETs has been recently shown to activate TRPV1 and TRPV4. 13, 29 These TRP proteins were expressed in PC12 cells. 30, 31 We investigated the , and that HC067047 is specific for TRPV4, because the IC50 value for TRPV4 were 100-fold higher for the closely related channels TRPV1, TRPV2, and TRPV3, and 10-fold higher for TRPM8 and hERG. 32 Furthermore, we used RN-1747 which has been identified as a specific TRPV4 agonist with EC50 values of 4 μmol L −1 (rat TRPV4). 5 μmol L Figures 5A and B) . In addition, 14,15-EET increased neurofilament-positive neurons which are thought to be mature axons 33 (Figure 5C ). In rat hippocampus, and cultured hippocampal neurons, expression of TRPV4 has been shown. 34 We found that a TRPV4 agonist, RN-1747 also enhanced neurite outgrowth of cells (Fig- ure 5B EET concentration was estimated to be 120 ng/g wet tissue in rat. 37 14,15-EET was mainly produced by rat CYP2C11, 2C13, and 2C23 from arachidonic acid. CYP2C13 reveals relatively low activity toward drugs and testosterone. 38, 39 We found that CYP2C13 efficiently produced 16-HETE and 14,15-EET from arachidonic acid.
| Enhancement of neurite outgrowth of rat primary cultured neuron by 14,15-EET
These results are consistent with those of El-Sheberi and El-Kadi 40 using the microsomes of cells expressing recombinant rat CYP2C13.
Although human CYP2J was isolated as an arachidonic acid epoxygenase, 41 rat CYP2J3 exhibited little epoxidase activity toward arachidonic acid in this study.
In this study, we detected 14,15-EET-producing P450s (CYP2C11, 2C13, and 2C23) in PC12 cells, and their inhibitor, ketoconazole, abrogated NGF-enhanced neurite outgrowth, suggesting the contribution of these P450s to neurogenesis. Ketoconazole also inhibit EET-induced relaxation in monkey cerebral artery. 42 Expression of CYP2C in rat brain has been shown in several reports. 23, 43 CYP2C11 is expressed in perivascular nerves in rat brain, 44 and CYP2C9 and 2C19 are detected in neuronal cells in humans, 45 sug- Our study suggests that arachidonic acid metabolites, 14,15-EETs, produced by cytochrome P450 contribute to neurite outgrowth through activation of TRPV4. Regulation of EET levels using sEH inhibitors, which hydrolyze EETs in the brain, has been explored as therapy for cerebral vascular diseases, such as stroke, because EETs will improve cerebral blood flow as vasodilators.
14 Therefore, the increase in EET levels by suppression of sEH activity in neuronal cells may also be effective in enhancing neurogenesis. 
